vs
Astrana Health, Inc.（ASTH）とPediatrix Medical Group, Inc.（MD）の財務データ比較。上の社名をクリックして会社を切り替えられます
Astrana Health, Inc.の直近四半期売上が大きい（$950.5M vs $493.8M、Pediatrix Medical Group, Inc.の約1.9倍）。Pediatrix Medical Group, Inc.の純利益率が高く（6.8% vs 0.7%、差は6.1%）。Astrana Health, Inc.の前年同期比売上増加率が高い（42.9% vs -1.7%）。過去8四半期でAstrana Health, Inc.の売上複合成長率が高い（53.3% vs -0.1%）
アストラナヘルス社は米国に本拠を置く価値基準型医療サービスプロバイダーで、主に米国全土の連邦医療保険対象高齢者層にサービスを提供している。訪問型プライマリケア、慢性疾患管理、ケアコーディネーションを通じ、患者の健康状態改善と不要な医療費削減を目指している。
Pediatrix Medical Group, Inc.は米国を代表する専門医療サービスプロバイダーで、母胎医療、新生児科、小児心臓病学などの小児亜専門を中心に事業を展開し、米国全土の医療機関と提携して女性、新生児、子どもに根拠に基づく質の高い医療を提供しています。
ASTH vs MD — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $950.5M | $493.8M |
| 純利益 | $6.6M | $33.7M |
| 粗利率 | — | — |
| 営業利益率 | 1.9% | 9.9% |
| 純利益率 | 0.7% | 6.8% |
| 売上前年比 | 42.9% | -1.7% |
| 純利益前年比 | 184.4% | 10.5% |
| EPS（希薄化後） | $0.12 | $0.40 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $950.5M | $493.8M | ||
| Q3 25 | $956.0M | $492.9M | ||
| Q2 25 | $654.8M | $468.8M | ||
| Q1 25 | $620.4M | $458.4M | ||
| Q4 24 | $665.2M | $502.4M | ||
| Q3 24 | $478.7M | $511.2M | ||
| Q2 24 | $486.3M | $504.3M | ||
| Q1 24 | $404.4M | $495.1M |
| Q4 25 | $6.6M | $33.7M | ||
| Q3 25 | $373.0K | $71.7M | ||
| Q2 25 | $9.4M | $39.3M | ||
| Q1 25 | $6.7M | $20.7M | ||
| Q4 24 | $-7.8M | $30.5M | ||
| Q3 24 | $16.1M | $19.4M | ||
| Q2 24 | $19.2M | $-153.0M | ||
| Q1 24 | $14.8M | $4.0M |
| Q4 25 | 1.9% | 9.9% | ||
| Q3 25 | 2.0% | 13.8% | ||
| Q2 25 | 3.1% | 12.8% | ||
| Q1 25 | 3.3% | 7.0% | ||
| Q4 24 | 0.1% | 7.8% | ||
| Q3 24 | 5.9% | 6.6% | ||
| Q2 24 | 6.2% | -31.3% | ||
| Q1 24 | 7.5% | 3.2% |
| Q4 25 | 0.7% | 6.8% | ||
| Q3 25 | 0.0% | 14.5% | ||
| Q2 25 | 1.4% | 8.4% | ||
| Q1 25 | 1.1% | 4.5% | ||
| Q4 24 | -1.2% | 6.1% | ||
| Q3 24 | 3.4% | 3.8% | ||
| Q2 24 | 3.9% | -30.3% | ||
| Q1 24 | 3.7% | 0.8% |
| Q4 25 | $0.12 | $0.40 | ||
| Q3 25 | $0.01 | $0.84 | ||
| Q2 25 | $0.19 | $0.46 | ||
| Q1 25 | $0.14 | $0.24 | ||
| Q4 24 | $-0.14 | $0.37 | ||
| Q3 24 | $0.33 | $0.23 | ||
| Q2 24 | $0.40 | $-1.84 | ||
| Q1 24 | $0.31 | $0.05 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $429.5M | $375.2M |
| 総負債低いほど良い | — | $570.5M |
| 株主資本純資産 | $779.3M | $865.9M |
| 総資産 | $2.2B | $2.2B |
| 負債/資本比率低いほどレバレッジが低い | — | 0.66× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $429.5M | $375.2M | ||
| Q3 25 | $463.4M | $340.1M | ||
| Q2 25 | $342.1M | $224.7M | ||
| Q1 25 | $260.9M | $99.0M | ||
| Q4 24 | $290.8M | $229.9M | ||
| Q3 24 | $350.3M | $103.8M | ||
| Q2 24 | $327.7M | $19.4M | ||
| Q1 24 | $337.3M | $8.0M |
| Q4 25 | — | $570.5M | ||
| Q3 25 | — | $577.2M | ||
| Q2 25 | — | $583.9M | ||
| Q1 25 | — | $590.5M | ||
| Q4 24 | — | $597.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $779.3M | $865.9M | ||
| Q3 25 | $775.5M | $890.7M | ||
| Q2 25 | $765.5M | $833.8M | ||
| Q1 25 | $745.4M | $789.2M | ||
| Q4 24 | $712.7M | $764.9M | ||
| Q3 24 | $704.6M | $732.5M | ||
| Q2 24 | $678.9M | $706.5M | ||
| Q1 24 | $653.5M | $856.2M |
| Q4 25 | $2.2B | $2.2B | ||
| Q3 25 | $2.2B | $2.2B | ||
| Q2 25 | $1.4B | $2.1B | ||
| Q1 25 | $1.3B | $2.0B | ||
| Q4 24 | $1.4B | $2.2B | ||
| Q3 24 | $1.3B | $2.1B | ||
| Q2 24 | $1.3B | $2.0B | ||
| Q1 24 | $1.2B | $2.2B |
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $-2.9M | $114.1M |
| フリーキャッシュフロー営業CF - 設備投資 | $-6.0M | — |
| FCFマージンFCF / 売上 | -0.6% | — |
| 設備投資強度設備投資 / 売上 | 0.3% | — |
| キャッシュ転換率営業CF / 純利益 | -0.44× | 3.39× |
| 直近12ヶ月FCF直近4四半期 | $104.5M | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $-2.9M | $114.1M | ||
| Q3 25 | $10.0M | $137.3M | ||
| Q2 25 | $90.9M | $137.2M | ||
| Q1 25 | $16.6M | $-117.5M | ||
| Q4 24 | $-10.9M | $133.0M | ||
| Q3 24 | $34.0M | $91.8M | ||
| Q2 24 | $23.2M | $107.0M | ||
| Q1 24 | $6.0M | $-125.2M |
| Q4 25 | $-6.0M | — | ||
| Q3 25 | $7.4M | — | ||
| Q2 25 | $89.5M | — | ||
| Q1 25 | $13.6M | — | ||
| Q4 24 | $-13.5M | — | ||
| Q3 24 | $31.7M | — | ||
| Q2 24 | $20.4M | — | ||
| Q1 24 | $5.6M | — |
| Q4 25 | -0.6% | — | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 13.7% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | -2.0% | — | ||
| Q3 24 | 6.6% | — | ||
| Q2 24 | 4.2% | — | ||
| Q1 24 | 1.4% | — |
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 0.6% | — | ||
| Q1 24 | 0.1% | — |
| Q4 25 | -0.44× | 3.39× | ||
| Q3 25 | 26.69× | 1.91× | ||
| Q2 25 | 9.65× | 3.49× | ||
| Q1 25 | 2.48× | -5.66× | ||
| Q4 24 | — | 4.36× | ||
| Q3 24 | 2.11× | 4.72× | ||
| Q2 24 | 1.21× | — | ||
| Q1 24 | 0.40× | -31.03× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
